Latest News

CORRECTION – Vocodia Announces Founder and Management Team Investments in Company IPO

CORRECTION – Vocodia Announces Founder and Management Team Investments in Company IPO

In a release issued under the same headline yesterday, March 26th, please note that the date of Vocodia's IPO completion should be February 26th, not February 22nd, as previously stated. The corrected release follows: CHICAGO, March 27, 2024 -- Vocodia Holdings Corp....

Clubhouse Media Group, Inc. Reports 2023 Financial Results, Highlighting Increased Revenue and Decreased Expenses

Clubhouse Media Group, Inc. Reports 2023 Financial Results, Highlighting Increased Revenue and Decreased Expenses

LOS ANGELES, March 27, 2024—Clubhouse Media Group, Inc. (OTC: CMGR ("Clubhouse Media"), a social media firm, today announced financial results for year-end 2023. The company has highlighted some of its financial achievements below. 2023 End of Year Summary...

PTOP Hires renowned Crypto Specialist @MoonMark_ (A.K.A) “DeFi Mark” to help implement MOBICOIN into MOBICARD™

PTOP Hires renowned Crypto Specialist @MoonMark_ (A.K.A) “DeFi Mark” to help implement MOBICOIN into MOBICARD™

CAMBRIDGE, MA, March 26, 2024 - Peer To Peer Network (OTC PINK: PTOP) ("PTOP") announces the addition of a well known coder. “Almost every company worldwide stands to benefit from integrating web3 technology; yet, many either fail to grasp its advantages or lack the...

American Shared Hospital Services Pays Tribute to Ernest A. Bates, M.D., Founder and Former Chairman and CEO

American Shared Hospital Services Pays Tribute to Ernest A. Bates, M.D., Founder and Former Chairman and CEO

Dr. Bates, Pioneering Neurosurgeon and Philanthropist, passed on March 19, 2024 SAN FRANCISCO, CA, March 26, 2024 - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery...

PRISM MARKETVIEW PREVIEWS ANTICIPATED FDA DRUG APPROVALS FOR 2024

PRISM MARKETVIEW PREVIEWS ANTICIPATED FDA DRUG APPROVALS FOR 2024

New York, N.Y., March 25, 2024 - PRISM MarketView - Drug development is an arduous, costly and time-consuming process for the teams involved behind the scenes, and the patients anxiously awaiting breakthroughs in different disease areas. It takes 12 years on average...